IL75800A - Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose - Google Patents

Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose

Info

Publication number
IL75800A
IL75800A IL75800A IL7580085A IL75800A IL 75800 A IL75800 A IL 75800A IL 75800 A IL75800 A IL 75800A IL 7580085 A IL7580085 A IL 7580085A IL 75800 A IL75800 A IL 75800A
Authority
IL
Israel
Prior art keywords
pharmaceutical formulations
amorphous lactose
ceftazidime pentahydrate
ceftazidime
pentahydrate
Prior art date
Application number
IL75800A
Other languages
English (en)
Other versions
IL75800A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24540922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL75800(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL75800A0 publication Critical patent/IL75800A0/xx
Publication of IL75800A publication Critical patent/IL75800A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
IL75800A 1984-07-23 1985-07-15 Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose IL75800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63373984A 1984-07-23 1984-07-23

Publications (2)

Publication Number Publication Date
IL75800A0 IL75800A0 (en) 1985-11-29
IL75800A true IL75800A (en) 1988-11-30

Family

ID=24540922

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75800A IL75800A (en) 1984-07-23 1985-07-15 Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose

Country Status (7)

Country Link
EP (1) EP0169700B1 (de)
JP (1) JPS6137728A (de)
CA (1) CA1249969A (de)
DE (1) DE3577656D1 (de)
IL (1) IL75800A (de)
NZ (1) NZ212763A (de)
ZA (1) ZA855365B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
RU2284832C2 (ru) * 2004-08-30 2006-10-10 Николай Александрович Киселев Антимикробная композиция для перорального введения
CN108272753A (zh) * 2018-02-07 2018-07-13 宁夏天心医药有限责任公司 一种头孢他啶粉针制剂及其制法
CN113101274B (zh) * 2021-03-31 2022-09-06 海南海灵化学制药有限公司 一种注射用头孢他啶粉针剂及其制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519237A (en) * 1978-07-27 1980-02-09 Toa Iyakuhin Kogyo Kk Crystalline lactose with high beta-lactose content and diluent comprising it
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
DE3577656D1 (de) 1990-06-21
IL75800A0 (en) 1985-11-29
EP0169700A3 (en) 1987-05-13
EP0169700A2 (de) 1986-01-29
JPS6137728A (ja) 1986-02-22
ZA855365B (en) 1987-02-25
CA1249969A (en) 1989-02-14
EP0169700B1 (de) 1990-05-16
NZ212763A (en) 1987-11-27

Similar Documents

Publication Publication Date Title
EP0172014A3 (en) Formulations of ibuprofen
GB2170400B (en) Caster
GB2166046B (en) Castors
IL75800A (en) Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
GB8623389D0 (en) Pharmaceutical formulations
GB8428952D0 (en) Formulations
DE3567016D1 (en) Benzamides and salts
JPS6434943A (en) Di-t-butylphenylalkyl and benzyl ether
EP0162690A3 (en) 2-oxa-spirocyclic-benzeneacetamides and benzamides
GB8505927D0 (en) Castors
GB8503253D0 (en) Aqueous formulations
GB8432255D0 (en) Castors
GB8612459D0 (en) Spray-dried material
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
GB2161374B (en) Castors
GB8710293D0 (en) Spray-dried material
GB8503221D0 (en) Pharmaceutical formulations
GB2153828B (en) New phenoxypropanolamine salts and pharmaceutical preparations thereof
GB8524568D0 (en) Agrochemical formulations
GB8419107D0 (en) Pharmaceutical formulations
GB8421741D0 (en) Pharmaceutical formulations
GB8421737D0 (en) Pharmaceutical formulations
GB8523690D0 (en) Formulations
GB8709508D0 (en) Benzamides & thiobenzamides
GB8717050D0 (en) Benzamides & thiobenzamides

Legal Events

Date Code Title Description
RH Patent void